5
2
↑0
↓5
—2
Evidence suggests Vitamin D maydecreasePain.
6 studies (7 claims)
Exact normalized-entity scope. Exact scope. Claims must match the selected normalized intervention and endpoint IDs; signal links are not expanded. Direction describes the stored endpoint phrase and is not a benefit/harm judgement.
8 of 8
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| vitamin D | Decreases - may constitute a safe, simple and potentially beneficial way to reduce | pain | Human | patients with vitamin D deficiency | Not specified | Vitamin D in Pain Management.cited 84× |
| vitamin D | Decreases - significant decrease | pain | Human | patients suffering from knee OA | Not specified in the abstract. | Symptomatic Efficacy of Pharmacological Treatments for Knee Osteoarthritis: A Systematic Review and a Network Meta-Analysis with a 6-Month Time Horizon.cited 36× |
| vitamin D | No effect - has also a role in | pain | Human | — | Not specified | Vitamin D: Vitamin or Hormone?cited 14× |
| Vitamin D | Decreases - demonstrated improvement | pain | Human | patients with knee and hip osteoarthritis | Not specified | The Efficacy and Safety of Disease-Modifying Osteoarthritis Drugs for Knee and Hip Osteoarthritis-a Systematic Review and Network Meta-Analysis.cited 26× |
| vitamin D | Decreases - deserve more careful attention | pain | Human | patients with chronic postoperative pain (CPSP) | Not specified | Non-drug pain relievers active on non-opioid pain mechanisms. |
| vitamin D | No effect - showed a treatment effect with 95% CIs that did not include an MCID for pain | pain | Human | women with stage I to III hormone receptor-positive breast cancer | Not specified | Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.cited 19× |
| vitamin D | Decreases - showed an MCID in pain scores which fell within the 95% CI of the measured effect | pain | Human | women with stage I to III hormone receptor-positive breast cancer | Not specified | Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.cited 19× |
| vitamin D | No effect - showed a treatment effect with 95% CI that did not include an MCID | pain | Human | women with stage I to III hormone receptor-positive breast cancer | Not specified | Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.cited 19× |